Home General Biotechnology FDA chief looks to speed diabetes, obesity drugs

FDA chief looks to speed diabetes, obesity drugs

FDA chief looks to speed diabetes, obesity drugs
Mark McClellan, commissioner of the Food and Drug Administration, said he wants to apply a fast-track review process normally reserved for drugs for terminal cancer and AIDS patients to drugs for diabetes and obesity.

NO COMMENTS

Leave a Reply